Biochemical large-scale identification of MHC class I ligands.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-62703-218-6_12PMID 23329485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catch me if you can: Mass spectrometry‐based phosphoproteomics and quantification strategies

  2011cited by this paper
• Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies.

  2008cited by this paper
• Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

  2007cited by this paper
• Comparative Study between Direct Mild Acid Extraction and Immunobead Purification Technique for Isolation of HLA Class I-Associated Peptides

  2002cited by this paper
• Identification of tumor‐associated MHC class I ligands by a novel T cell‐independent approach

  2000cited by this paper
• SYFPEITHI: database for MHC ligands and peptide motifs

  1999cited by this paper
• Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.

  1999cited by this paper
• Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501

  1997cited by this paper
• Analysis of a naturally occurring HLA class I-restricted viral epitope.

  1994cited by this paper
• Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.

  1993cited by this paper
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

  1991cited by this paper
• Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule

  1990cited by this paper
• HLA‐DA monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cell

  1982cited by this paper
• Monoclonal Antibody to HLA-A3

  1982cited by this paper
• HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells.

  1982cited by this paper
• Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

  1981cited by this paper
• Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

  1978cited by this paper

• A platform for high-throughput and ultrasensitive immunopeptidomics

  2026influential citation
• Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasis

  2025cites this paper
• Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics

  2025cites this paper
• Myeloid cell MHC I expression drives CD8+ T cell activation in nonalcoholic steatohepatitis

  2024cites this paper
• Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes

  2024cites this paper
• Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements

  2023cites this paper
• Targeting of intracellular oncoproteins with peptide-centric CARs

  2023cites this paper
• Peptide-based vaccine for cancer therapies

  2023cites this paper
• The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination

  2023cites this paper
• T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells

  2022cites this paper
• Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.

  2022cites this paper
• Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma.

  2022cites this paper
• Identification and Mitigation of Defensins in the Immunopurification of Peptide MHC-I Antigens from Lung Tissue.

  2021cites this paper
• Characterization of HLA-A*02:01 MHC Immunopeptide Antigens Enhanced by Ultraviolet Photodissociation Mass Spectrometry.

  2021cites this paper
• Argyrin F Treatment‐Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma

  2021cites this paper
• Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue

  2021cites this paper
• Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions

  2021cites this paper
• Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities

  2021cites this paper
• RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

  2021cites this paper
• Immunogenicity and Immune Silence in Human Cancer

  2020cites this paper
• Immunopeptidome | Encyclopedia

  2020cites this paper
• Automated Ligand Purification Platform Accelerates Immunopeptidome Analysis by Mass Spectrometry.

  2020cites this paper
• Critical Review of Existing MHC I Immunopeptidome Isolation Methods

  2020cites this paper
• Immunopeptidomics for Dummies: Detailed Experimental Protocols and Rapid, User-Friendly Visualization of MHC I and II Ligand Datasets with MhcVizPipe

  2020cites this paper
• Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process

  2020cites this paper
• Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire

  2020cites this paper
• Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

  2020cites this paper
• Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses

  2020influential citation
• Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo

  2020cites this paper
• Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies*

  2020cites this paper
• High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.

  2019cites this paper
• Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.

  2019cites this paper
• Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

  2019cites this paper
• Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.

  2019cites this paper
• HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11

  2019cites this paper
• MHC-II neoantigens shape tumor immunity and response to immunotherapy

  2019cites this paper
• A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

  2019cites this paper
• A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

  2019cites this paper
• Validation of a high-performance liquid chromatography-tandem mass spectrometry immunopeptidomics assay for the identification of HLA class I ligands suitable for pharmaceutical therapies

  2019cites this paper
• Proteogenomic discovery of cancer antigens: Neoantigens and beyond

  2019cites this paper
• Improved Ribo-seq enables identification of cryptic translation events

  2018cites this paper
• Minimal Information About an Immuno‐Peptidomics Experiment (MIAIPE)

  2018cites this paper
• Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

  2018cites this paper
• Ermittlung der Bindespezifitäten für das canine MHC-Klasse-I-Allel DLA-88*03201 sowie vergleichende Betrachtung viraler und zellulärer Liganden von DLA-88*50101 und HLA-A*02:01

  2018influential citation
• Applied immunoinformatics: HLA peptidome analysis for cancer immunotherapy

  2018cites this paper
• The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy

  2018cites this paper
• CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival

  2018cites this paper
• Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma

  2018cites this paper
• The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

  2018cites this paper
• TAPBPR mediates peptide dissociation from MHC class I using a leucine lever

  2018cites this paper
• Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry

  2018cites this paper
• The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer

  2018cites this paper
• High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome

  2017cites this paper
• A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens

  2017cites this paper
• Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma

  2017cites this paper
• Identification of Immunogenic Epitopes by MS/MS

  2017cites this paper
• Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

  2017cites this paper
• High-throughput and sensitive immunopeptidomics platform reveals profound (cid:44)(cid:41)(cid:49)(cid:534) -mediated remodeling of the HLA ligandome

  2017cites this paper
• HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

  2017cites this paper
• MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.

  2017cites this paper
• Caractérisation topologique d'interactions non-covalentes inter- et intramoléculaires

  2017cites this paper
• Advanced Immunoinformatics Approaches for Precision Medicine

  2016cites this paper
• Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy

  2016cites this paper
• Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells

  2016cites this paper
• Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

  2016cites this paper
• Carcinogenesis of renal cell carcinoma reflected in HLA ligands: A novel approach for synergistic peptide vaccination design

  2016cites this paper
• Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini

  2016cites this paper
• Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses

  2016cites this paper
• Erratum to “Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient”

  2016cites this paper
• Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry*

  2015cites this paper
• The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.

  2015cites this paper
• An open-source computational and data resource to analyze digital maps of immunopeptidomes

  2015cites this paper
• Inhibition de prmt5 dans le traitement de maladies liées à une déficience en mtap

  2015cites this paper
• Identification of a Novel Immunodominant HLA-B*07: 02-restricted Adenoviral Peptide Epitope and Its Potential in Adoptive Transfer Immunotherapy

  2015cites this paper
• HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy

  2015cites this paper
• Efficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection.

  2015cites this paper
• Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

  2015cites this paper
• Correction for “ HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia ( CLL )

  2015cites this paper
• A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy

  2015cites this paper
• Analysis of MHC immunopeptidomes using mass

  2015cites this paper
• Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

  2014cites this paper
• Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

  2014cites this paper
• HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)

  2014cites this paper
• HLA ligandome tumor antigen discovery for personalized vaccine approach

  2013cites this paper
• Exploring the MHC-peptide matrix of central tolerance in the human thymus

  2013cites this paper
• A natural tapasin isoform lacking exon 3 modifies peptide loading complex function

  2013cites this paper
• Bioorthogonal antigens as tool for investigation of antigen processing and presentation

  year unknowncites this paper